| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 02/28/2002 | CA2415788A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors |
| 02/27/2002 | EP1182183A1 Anthracene derivatives and organic electroluminescent devices made by using the same |
| 02/27/2002 | EP1181940A2 In vivo diagnostics by near infrared radiation |
| 02/27/2002 | EP1181335A1 Extended rhodamine compounds useful as fluorescent labels |
| 02/27/2002 | EP1181280A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides |
| 02/27/2002 | EP1181276A1 Morpholino-n-ethyl ester derivative of an indole spla-2 inhibitor |
| 02/27/2002 | EP1181275A1 Thio-oxindole derivatives |
| 02/27/2002 | EP1181269A1 Cell proliferation inhibitors |
| 02/27/2002 | EP0817770B1 Nonpeptides as tachykinin antagonists |
| 02/27/2002 | EP0729945B1 Photopolymerizable composition containing squarylium compound |
| 02/27/2002 | EP0687251B1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 02/27/2002 | CN1337994A Bleaching compositions |
| 02/27/2002 | CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 02/27/2002 | CN1337932A Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treamtent of respiratory diseases |
| 02/27/2002 | CN1337851A Converting COX-2 inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors |
| 02/27/2002 | CN1337395A Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/26/2002 | US6350885 Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases |
| 02/26/2002 | US6350875 Synthesis of cyclooctatetraene derivatives and their use as electron transporters in organic light emitting diodes |
| 02/26/2002 | US6350754 3-(cycloalkanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors |
| 02/26/2002 | US6350749 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| 02/26/2002 | US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/26/2002 | CA2024672C Indole, benzofuran,and benzothiophene containing lipoxygenase inhibiting compounds |
| 02/21/2002 | WO2002014294A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
| 02/21/2002 | WO2002014278A1 Processes for preparation of bicyclic compounds and intermediates therefor |
| 02/21/2002 | WO2002014275A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
| 02/21/2002 | WO2002014274A1 Selective urokinase inhibitors |
| 02/21/2002 | WO2002014273A1 Indoline derivatives as 5ht2c antagonists |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | WO2002014265A1 Novel 3-substituted urea derivatives and medicinal use thereof |
| 02/21/2002 | WO2002014261A2 4-substituted d-glutamic acid derivatives for use as antibiotic |
| 02/21/2002 | WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 02/21/2002 | WO2001019791A3 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments |
| 02/21/2002 | US20020022637 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/21/2002 | US20020022626 Creating a combinatorial library of indolinones by reacting a series of oxindoles with a series of aldehydes, testing oxindolinones in biological assays, selecting and synthesizing one or more indolinones with favorable activity |
| 02/21/2002 | US20020022624 Azaindole derivatives and their use as therapeutic agents |
| 02/21/2002 | US20020022617 Methods for increasing nitric oxide synthase activity |
| 02/21/2002 | US20020022575 Dialkyl-halogenophenyl-substituted ketoenols |
| 02/21/2002 | US20020022237 Encoding metal salts are impregnated onto the support unit, with isotope distribution of the metal in the salt used as code; insoluble metal salts are formed to improve metal's retention |
| 02/21/2002 | US20020020832 Photosensitive resin composition |
| 02/20/2002 | EP1180514A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| 02/20/2002 | CN1336924A Amide and urea derivatives as 5-HT reuptake inhibitors and at 5-HT 1B/1D ligands |
| 02/20/2002 | CN1336916A Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 02/20/2002 | CN1336364A Prepn. of 2,2'-di(N-methylphthalimido-4-phenoxy) propane |
| 02/20/2002 | CN1336356A Method for prepn. of alkaline organic nitrogen-contg. compound by using aluminium lithium oxide reduction method |
| 02/20/2002 | CN1079395C Process for prepn. of N-acetyl-5,6-dimethoxyl-tryptamine |
| 02/19/2002 | US6348487 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 02/19/2002 | US6348486 Methods for modulating bladder function |
| 02/19/2002 | US6348478 Biphenylamidine derivatives |
| 02/19/2002 | CA2058754C Divalent metal salts of indomethacin |
| 02/19/2002 | CA2017217C Amino acid derivative anticonvulsant |
| 02/14/2002 | WO2002012189A1 Fused bicyclic amide compounds and medicinal use thereof |
| 02/14/2002 | WO2002012178A1 Compounds acting as melanocortin receptor ligands |
| 02/14/2002 | WO2002012166A2 Triamine derivative melanocortin receptor ligands and methods of using same |
| 02/14/2002 | WO2001068603A3 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 02/14/2002 | WO2001051479A3 Tricyclic compounds with antiviral activity |
| 02/14/2002 | US20020019540 Conformationally constrained compounds as pharmaceutical agents |
| 02/14/2002 | US20020019434 Indole derivatives having an antiviral activity |
| 02/14/2002 | US20020019416 Esters and amides as pla2 inhibitors |
| 02/14/2002 | US20020019412 Antidiabetic agents |
| 02/14/2002 | US20020019411 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 02/14/2002 | US20020019401 Psychological disorders; adjustment of dopamine concentration |
| 02/14/2002 | US20020019382 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 02/14/2002 | US20020019380 1-(6-((dimethylamino)methyl)-1-methyl-2,3,5,6-tetrahydro-1H -cyclobuta(f)indol-6-yl)cyclohexanol, for example; treating psychological disorders such as depression, panic attacks, phobias, drug abuse, as well as obesity and bulemia |
| 02/14/2002 | US20020018912 Transistors, liquid crystal display, electrooptics |
| 02/14/2002 | DE10037408A1 Verfahren zur Herstellung von basisch reagierenden, organischen, stickstoffhaltigen Verbindungen durch Reduktion mit Lithiumaluminiumhydrid Process for the preparation of basic organic nitrogen-containing compounds by reduction with lithium aluminum hydride |
| 02/13/2002 | EP1179342A1 Immediate release medicinal compositions for oral use |
| 02/13/2002 | EP1178987A1 Substituted benzoylisoxazoles and the use thereof as herbicides |
| 02/13/2002 | EP1178983A1 Indole-type derivatives as inhibitors of p38 kinase |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP1178802A1 Cyclic amidines useful as nmda nr2b antagonists |
| 02/13/2002 | EP1178800A1 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 02/13/2002 | EP1178794A1 Use of succinic acid derivatives to obtain a medicine for treating inflammation |
| 02/13/2002 | EP1178792A1 Aryl amidines, compositions containing such compounds and methods of use |
| 02/13/2002 | EP0861236B1 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 02/13/2002 | CN1079097C Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives |
| 02/12/2002 | US6346621 Indole or quinoline compounds substituted with amino compounds on nitrogen |
| 02/12/2002 | CA2048139C N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 02/07/2002 | WO2002010177A1 Ammonium salts of inositol hexaphosphate and uses thereof |
| 02/07/2002 | WO2002010174A1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b][1,3]benzotiazepines |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002009760A2 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 02/07/2002 | WO2002009702A2 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 02/07/2002 | WO2001083439A3 Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |
| 02/07/2002 | US20020016474 Tetramers of acetylene or diacetylenes catalyzed by a dihydridocarbonyltris/triphenylphosphine/ruthenium complex or a nickel complex; asymmetrical |
| 02/07/2002 | US20020016462 Producing 3-amino-1-benzylpyrrolidine and 8-benzyl-2,8-diaza bicyclo(4.3.0)-nonane; reaction mixture added to an aqueous solution in which substances containging alpha-hydroxy carboxyl and/or alpha-aminocarboxyl groups are dissolved |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016354 Treatment of respiratory diseases, convulsions, vascular disorders, renal disorders, urinary disorders, Alzheimer's disease, dysmenorrhea, narcolepsy |
| 02/07/2002 | US20020016353 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions |
| 02/07/2002 | US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha |
| 02/07/2002 | US20020016339 Anticoagulants |
| 02/07/2002 | US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use |
| 02/07/2002 | US20020016298 Facilitate secretion of growth hormone (GH) by the anterior pituitary. |
| 02/07/2002 | DE10031391A1 Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie Bicyclic compounds and their use for the prophylaxis and therapy of cerebral ischemia |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | CA2417489A1 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 02/07/2002 | CA2415789A1 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 02/06/2002 | EP1178040A1 Nickel catalyzed addition of -NH- containing compounds to vinyl and aryl halides |
| 02/06/2002 | EP1178039A1 Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides |
| 02/06/2002 | EP1177792A2 Dopamine D4 Ligands for the treatment of novelty-seeking disorders |